Current
Neuro-Oncology


Volume 21 Number 5
January 2019


Home > Disciplines > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 5, May


CONTENTS


GLIOMAS
BRAIN STEM GLIOMAS
DIFFUSE MIDLINE GLIOMAS
HIGH-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA

OTHER GLIOMAS
ASTROBLASTOMA

EMBRYONAL TUMORS
MEDULLOBLASTOMA
ATYPICAL THERATOID/RHABDOID TUMOR





GLIOMAS

.

Raman R, Raman A.
A pituitary tumor turned-to-be a glioma: A surgical case from the Madras General Hospital 1928.
Indian J Cancer. 2018 Oct-Dec;55(4):424-427. doi: 10.4103/ijc.IJC_12_19.
Source | Full text | Similar articles



BRAIN STEM GLIOMAS




DIFFUSE MIDLINE GLIOMAS


.

Akamandisa MP, Nie K, Nahta R, Hambardzumyan D, Castellino RC.
Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
Neuro Oncol. 2019 Mar 10. pii: noz053. doi: 10.1093/neuonc/noz053. [Epub ahead of print]
Source | Full text | Similar articles



.

Deweyert A, Iredale E, Xu H, Wong E, Schmid S, Hebb MO.
Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.
J Neurooncol. 2019 Mar 9. doi: 10.1007/s11060-019-03145-8. [Epub ahead of print]
Source | Full text | Similar articles



.

Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, Janssen G, Graf N, Rutkowski S, Beilken A, Schmid I, Biassoni V, Gorelishev SK, Kramm C, Reinhard H, Schlegel PG, Kortmann RD, Reuter D, Bach F, Iznaga-Escobar NE, Bode U.
Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
J Neurooncol. 2019 Mar 4. doi: 10.1007/s11060-019-03140-z. [Epub ahead of print]
Source | Full text | Similar articles




Mueller S, Jain P, Liang WS, Kilburn L, Kline C, Gupta N, Panditharatna E, Magge SN, Zhang B, Zhu Y, Crawford JR, Banerjee A, Nazemi K, Packer RJ, Petritsch CK, Truffaux N, Roos A, Nasser S, Phillips JJ, Solomon D, Molinaro A, Waanders AJ, Byron SA, Berens ME, Kuhn J, Nazarian J, Prados M, Resnick AC.
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium.
Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32258. [Epub ahead of print]
Source | Full text | Similar articles



.

Schreck KC, Ranjan S, Skorupan N, Bettegowda C, Eberhart CG, Ames HM, Holdhoff M.
Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
J Neurooncol. 2019 Mar 12. doi: 10.1007/s11060-019-03134-x. [Epub ahead of print]
Source | Full text | Similar articles



.

Sridhar K, Srinivasan K.
Diffusion tensor imaging and tractography in diffuse intrinsic pontine glioma - A major determinant of resectability and description of a new subtype.
Neurol India. 2019 Jan-Feb;67(1):292-297. doi: 10.4103/0028-3886.253625.
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS


.

Kebir S, Rauschenbach L, Radbruch A, Lazaridis L, Schmidt T, Stoppek AK, Pierscianek D, Stuschke M, Forsting M, Sure U, Keyvani K, Kleinschnitz C, Scheffler B, Glas M.
Regorafenib in patients with recurrent high-grade astrocytoma.
J Cancer Res Clin Oncol. 2019 Apr;145(4):1037-1042. doi: 10.1007/s00432-019-02868-5. Epub 2019 Feb 28.
Source | Full text | Similar articles




Kieran MW, Goumnerova L, Manley P, Chi SN, Marcus KJ, Manzanera AG, Polanco MLS, Guzik BW, Aguilar-Cordova E, Diaz-Montero CM, DiPatri AJ, Tomita T, Lulla R, Greenspan L, Aguilar LK, Goldman S.
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.
Neuro Oncol. 2019 Mar 18;21(4):537-546. doi: 10.1093/neuonc/noy202.
Source | Full text | Similar articles



.

Song A, Andrews DW, Werner-Wasik M, Kim L, Glass J, Bar-Ad V, Evans JJ, Farrell CJ, Judy KD, Daskalakis C, Zhan T, Shi W.
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.
Radiother Oncol. 2019 Mar;132:135-141. doi: 10.1016/j.radonc.2018.12.019. Epub 2019 Jan 4.
Source | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA


.

Buchmann N, Gempt J.
In Reply to Letter to the Editor Regarding "Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?"
World Neurosurg. 2019 Mar;123:470. doi: 10.1016/j.wneu.2018.12.019. Epub 2019 Jan 17.
Source | Full text | Similar articles
Comment on: Fang X et al., Letter to the Editor Regarding "Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?"
World Neurosurg. 2019 Mar;123:469. doi: 10.1016/j.wneu.2018.10.050. Available online 26 February 2019.
Source / Full text
In turn Comment on: Buchmann N et al., Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?
World Neurosurg. 2019 Jan;121:e467-e474. doi: 10.1016/j.wneu.2018.09.139. Epub 2018 Sep 27.
Source / Full text



.

Fang X, Kong W, Yu Z, Qiu J, Duan H.
Letter to the Editor Regarding "Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?"
World Neurosurg. 2019 Mar;123:469. doi: 10.1016/j.wneu.2018.10.050. Available online 26 February 2019.
Source | Full text | Similar articles
Comment on: Buchmann N et al., Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?
World Neurosurg. 2019 Jan;121:e467-e474. doi: 10.1016/j.wneu.2018.09.139. Epub 2018 Sep 27.
Source / Full text



.

Hui CY, Rudra S, Ma S, Campian JL, Huang J.
Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients.
J Neurooncol. 2019 Mar 12. doi: 10.1007/s11060-019-03146-7. [Epub ahead of print]
Source | Full text | Similar articles



.

Krenzlin H, Behera P, Lorenz V, Passaro C, Zdioruk M, Nowicki MO, Grauwet K, Zhang H, Skubal M, Ito H, Zane R, Gutknecht M, Griessl MB, Ricklefs F, Ding L, Peled S, Rooj A, James CD, Cobbs CS, Cook CH, Chiocca EA, Lawler SE.
Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis.
J Clin Invest. 2019 Mar 11;130:1671-1683. doi: 10.1172/JCI123375. eCollection 2019 Mar 11.
Source | Full text | Similar articles



.

Lesueur P, Lequesne J, Grellard JM, Dugué A, Coquan E, Brachet PE, Geffrelot J, Kao W, Emery E, Berro DH, Castera L, Goardon N, Lacroix J, Lange M, Capel A, Leconte A, Andre B, Léger A, Lelaidier A, Clarisse B, Stefan D.
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
BMC Cancer. 2019 Mar 4;19(1):198. doi: 10.1186/s12885-019-5413-y.
Source | Full text | Similar articles



.

Santos VM, Marta GN, Mesquita MC, Lopez RVM, Cavalcante ER, Feher O.
The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma.
J Neurooncol. 2019 Mar 8. doi: 10.1007/s11060-019-03137-8. [Epub ahead of print]
Source | Full text | Similar articles



.

Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.
Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.
Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052.
Source | Full text | Similar articles



.

Xiao A, Brenneman B, Floyd D, Comeau L, Spurio K, Olmez I, Lee J, Nakano I, Godlewski J, Bronisz A, Kagaya N, Shin-Ya K, Purow B.
Statins affect human glioblastoma and other cancers through TGF-β inhibition.
Oncotarget. 2019 Mar 1;10(18):1716-1728. doi: 10.18632/oncotarget.26733. eCollection 2019 Mar 1.
Source | Full text | Similar articles



OTHER GLIOMAS



ASTROBLASTOMA


.

Bhalerao S, Nagarkar R, Adhav A.
A case report of high-grade astroblastoma in a young adult.
CNS Oncol. 2019 Mar;8(1):CNS29. doi: 10.2217/cns-2018-0012. Epub 2019 Feb 28.
Source | Full text | Similar articles



EMBRYONAL TUMORS



MEDULLOBLASTOMA


.

Minasi S, Baldi C, Pietsch T, Donofrio V, Pollo B, Antonelli M, Massimino M, Giangaspero F, Buttarelli FR.
Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
J Neurooncol. 2019 Mar 4. doi: 10.1007/s11060-019-03127-w. [Epub ahead of print]
Source | Full text | Similar articles



.

Nobre L, Pauck D, Golbourn B, Maue M, Bouffet E, Remke M, Ramaswamy V.
Effective and safe tumor inhibition using vinblastine in medulloblastoma.
Pediatr Blood Cancer. 2019 Jun;66(6):e27694. doi: 10.1002/pbc.27694. Epub 2019 Mar 8.
Source | Full text | Similar articles



.

Sherif RS, Elshemey WM, Attalla EM.
The risk of secondary cancer in pediatric medulloblastoma patients due to three-dimensional conformal radiotherapy and intensity-modulated radiotherapy.
Indian J Cancer. 2018 Oct-Dec;55(4):372-376. doi: 10.4103/ijc.IJC_410_18.
Source | Full text | Similar articles



.

Vargas López AJ, Sola Vendrell E, Fernández Carballal C.
Late recurrence of medulloblastoma after 17 years of complete remission.
J Clin Neurosci. 2019 Mar 21. pii: S0967-5868(19)30235-8. doi: 10.1016/j.jocn.2019.03.028. [Epub ahead of print]
Source | Full text | Similar articles



ATYPICAL THERATOID/RHABDOID TUMOR


.

Isikay I, Hanalioglu S, Basar I, Narin F, Bilginer B.
Survival Benefit with Gross Total Resection and Adjuvant Radiotherapy in Childhood Atypical Teratoid/Rhabdoid Tumors: Results of a Single-Center Cohort of 27 Cases.
Turk Neurosurg. 2019 Feb 4. doi: 10.5137/1019-5149.JTN.25406-18.1. [Epub ahead of print]
Source | Full text | Similar articles



bottom